Proof of rebamipide induced mucosal effect for NSAIDs injuries of small bowel
Phase 4
- Conditions
- SAIDs induced mucosal injuries of small bowel
- Registration Number
- JPRN-UMIN000006625
- Lead Sponsor
- Hokkaido small bowel disease conference
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
(1)Patients who need active treatment for small bowel lesion (2)Patients who have hitstory of small bowel disease such as Crohn's disease (3)Patients whose lesions are associated with other factors except NSAIDs (4)Patients who need high-dose streoid therapy (5)Contraindication of capsule endoscopy (6)Patients who have severe liver, renal, and cardiopulmonary dysfunctions, malignant diseases (7)Pregnant patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method